Risk of Hepatotoxicity in Cancer Patients Treated With Immune Checkpoint Inhibitors: A Systematic Review and Meta-Analysis of Published Data

International Journal of Cancer - United States
doi 10.1002/ijc.30678
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Wiley

Related search

Risk of Myocarditis in Patients With Cancer Treated With Immune Checkpoint Inhibitors

Chronicles of Oncology
2018English

Risk of Pneumonitis and Pneumonia Associated With Immune Checkpoint Inhibitors for Solid Tumors: A Systematic Review and Meta-Analysis

Frontiers in Immunology
AllergyImmunology
2019English

Immune-Related Adverse Effects and Outcome of Patients With Cancer Treated With Immune Checkpoint Inhibitors

Anticancer Research
MedicineCancer ResearchOncology
2020English

Alpha-Glucosidase Inhibitors and Risk of Cancer in Patients With Diabetes Mellitus: A Systematic Review and Meta-Analysis

Oncotarget
Oncology
2017English

Review of Cancer Treatment With Immune Checkpoint Inhibitors

Wiener Klinische Wochenschrift
Medicine
2017English

Evaluation of Classical Clinical Endpoints as Surrogates for Overall Survival in Patients Treated With Immune Checkpoint Blockers: A Systematic Review and Meta-Analysis

Journal of Cancer Research and Clinical Oncology
MedicineCancer ResearchOncology
2018English

Impact of Patient’s Age on Efficacy of Immune Checkpoint Inhibitors in Advanced Cancers: A Systematic Review and Meta-Analysis

International Journal of Radiation Oncology Biology Physics
OncologyRadiologyCancer ResearchRadiationNuclear MedicineImaging
2019English

Retreatment With Immune Checkpoint Inhibitors in Solid Tumors: A Systematic Review

2020English

Risk of Second Primary Cancers in Cancer Patients Treated With Cisplatin: A Systematic Review and Meta-Analysis of Randomized Studies

BMC Cancer
Cancer ResearchOncologyGenetics
2017English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy